NZ Rheumatology Research Review Issue 57
In this issue:
– RA comorbidity clusters identify phenotype with favourable prognosis
– SGLT-2 inhibitors and nephritis in SLE
– Biological use influences impact of inflammation on CV event risk in RA
– Temporal artery ultrasonography when clinical suspicion of GCA is high
– Cost-effectiveness of biosimilars vs. leflunomide in RA
– Concomitant septic and crystal arthropathy
– First-line biological DMARDs in RA + CKD
– Approaches to acute AAV in Australasia
– Anti-TNF ± NSAID in radiographic axial SpA
– Corticoid-sparing methotrexate and leflunomide for polymyalgia rheumatica
Expert contributor
Professor Simon Stebbings
Simon Stebbings qualified from University College London. He is a Consultant Rheumatologist at Dunedin Hospital and Professor at Dunedin School of Medicine, University of Otago. His research interests include the pathogenesis of ankylosing spondylitis and the development of outcome measures in rheumatic disease. Professor Stebbings provides expert commentary for Rheumatology Research Review.
Expert contributor
Associate Professor Andrew Harrison
Andrew Harrison is a rheumatologist based in Wellington, Associate Professor in Medicine at the University of Otago Wellington, and Medical Director of Arthritis New Zealand. He is an Otago graduate and obtained his PhD from the Royal Postgraduate Medical School in London. His research interests include the basic cellular and molecular mechanisms of inflammation, the […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.
